These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16416192)

  • 1. Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis.
    Muratori L; Ferrari R; Muratori P; Granito A; Bianchi FB
    Dig Dis Sci; 2005 Dec; 50(12):2364-5. PubMed ID: 16416192
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis.
    Chow SK; Looi LM; Loh CS; Yeap SS
    Intern Med J; 2002 Mar; 32(3):114-6. PubMed ID: 11885838
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe and prolonged jaundice in a lupus nephritis patient treated with cyclophosphamide.
    Moroni G; Maccario M; Fargion S; Ponticelli C
    Nephrol Dial Transplant; 1997 Apr; 12(4):793-6. PubMed ID: 9141016
    [No Abstract]   [Full Text] [Related]  

  • 4. Updates on the treatment of lupus nephritis.
    Bomback AS; Appel GB
    J Am Soc Nephrol; 2010 Dec; 21(12):2028-35. PubMed ID: 21051743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis.
    Gibbons RB; Westerman E
    Arthritis Rheum; 1988 Dec; 31(12):1552-4. PubMed ID: 3196367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential therapies for proliferative lupus nephritis.
    Yee CS; Gordon C
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15190147
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
    Illei GG; Yarboro CH; Kuroiwa T; Schlimgen R; Austin HA; Tisdale JF; Chitkara P; Fleisher T; Klippel JH; Balow JE; Boumpas DT
    Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kava-induced acute icteric hepatitis].
    Bujanda L; Palacios A; Silvariño R; Sánchez A; Muñoz C
    Gastroenterol Hepatol; 2002; 25(6):434-5. PubMed ID: 12069710
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lupus nephritis].
    Oberle GP; Helmchen U; Stahl RA
    Internist (Berl); 1995 Mar; 36(3):236-44. PubMed ID: 7737816
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.
    Tse KC; Tang CS; Lio WI; Lam MF; Chan TM
    Lupus; 2006; 15(6):371-9. PubMed ID: 16830884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).
    Calguneri M; Ozbalkan Z; Ozturk MA; Apras S; Ertenli AI; Kiraz S
    Clin Rheumatol; 2006 Nov; 25(6):782-8. PubMed ID: 16547692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S; Kaneko K; Ohtomo Y; Murakami H; Takada M; Akashi S; Hira M; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.
    Boletis JN; Ioannidis JP; Boki KA; Moutsopoulos HM
    Lancet; 1999 Aug; 354(9178):569-70. PubMed ID: 10470708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study.
    Houssiau FA; D'Cruz DP; Haga HJ; Hughes GR
    Lupus; 1991 Nov; 1(1):31-5. PubMed ID: 1845361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy in lupus nephritis.
    D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide in lupus nephritis.
    Houssiau FA
    Lupus; 2005; 14(1):53-8. PubMed ID: 15732289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?
    Hogan J; Schwenk MH; Radhakrishnan J
    Kidney Int; 2012 Dec; 82(12):1256-60. PubMed ID: 22648298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.